Dyslipidemia regulates both innate and adaptive immune reaction by releasing pro-inflammatory cytokines, which contribute to the activation and polarization of T-helper 2 (Th-2) and Th17 as well as inhibiting interleukin-10 (IL-10) cytokine production [7]. Here, IL10 is linked to metabolic syndrome.